VAERS Table f Reprtable Events Fllwing Vaccinatin* Vaccine/Txid Tetanus in any cmbinatin; DTaP, DTP, DTP-Hib, DT, Td, TT, Tdap, DTaP-IPV, DTaP-IPV/Hib, DTaP- HepB-IPV Event and interval frm vaccinatin B. Brachial neuritis (28 days) C. Any acute cmplicatins r sequelae (including death) D. - see Pertussis in any cmbinatin; DTaP, DTP, DTP- Hib, Tdap, P, DTaP-IPV, DTaP-IPV/Hib, DTaP- HepB-IPV B. Encephalpathy r encephalitis (7 days) C. Any acute cmplicatins r sequelae (including death) D. - see Measles, mumps and rubella in any cmbinatin; MMR, MR, M, MMRV, R B. Encephalpathy r encephalitis (15 days) C. Any acute cmplicatins r sequelae (including death) D. - see Rubella in any cmbinatin; MMR, MMRV, MR, R A. Chrnic arthritis (42 days) B. Any acute cmplicatins r sequelae (including death) f abve event (interval - nt applicable) C. - see Measles in any cmbinatin; MMR, MMRV, MR, M A. Thrmbcytpenic purpura (7-30 days) B. Vaccine-strain measles viral infectin in an immundeficient recipient (6 mnths) C. Any acute cmplicatins r sequelae (including death) D. - see Oral Pli (OPV) A. Paralytic pli in a nn-immundeficient recipient (30 days) in an immundeficient recipient (6 mnths) in a vaccine-assciated cmmunity case (interval - nt applicable) B. Vaccine-strain pli viral infectin in a nn-immundeficient recipient (30 days) in an immundeficient recipient (6 mnths)
VAERS Table f Reprtable Events Fllwing Vaccinatin* Vaccine/Txid Event and interval frm vaccinatin in a vaccine-assciated cmmunity case (interval - nt applicable) C. Any acute cmplicatin r sequelae (including death) f abve events (interval - nt applicable) D. - see Inactivated Pli -IPV, DTaP-IPV, DTaP-IPV/HIB, DTaP-HepB-IPV B. Any acute cmplicatin r sequelae (including death) f the abve event (interval - nt applicable) C. - see Hepatitis B in any cmbinatin- HepB, HepA- HepB, DTaP-HepB-IPV, Hib-HepB B. Any acute cmplicatins r sequelae (including death) f the abve event (interval - nt applicable) C. - see Hemphilus influenzae type b in any cmbinatin (cnjugate)- Hib, Hib-HepB, DTP-Hib, DTaP- IPV/Hib Varicella in any cmbinatin- VAR, MMRV Rtavirus (mnvalent r pentavalent) RV1, RV5 Pneumcccal cnjugate (7-valent r 13-valent) PCV7, PCV13 - see - see - see - see Hepatitis A in any cmbinatin- HepA, HepA-HepB Influenza--trivalent inactivated influenza, live - see - see
VAERS Table f Reprtable Events Fllwing Vaccinatin* Vaccine/Txid Event and interval frm vaccinatin attenuated influenza TIV, LAIV Meningcccal - MCV4, MPSV4 Human Papillmavirus (Quadrivalent r Bivalent)- HPV4, HPV2 - see - see * Effective date: Nvember 10, 2008. The Reprtable Events Table (RET) reflects what is reprtable by law (42 USC 300aa-25) t the Vaccine Adverse Event Reprting System (VAERS) including cnditins fund in the manufacturers package insert. In additin, healthcare prfessinals are encuraged t reprt any clinically significant r unexpected events (even if yu are nt certain the vaccine caused the event) fr any vaccine, whether r nt it is listed n the RET. Manufacturers are als required by regulatin (21CFR 600.80) t reprt t the VAERS prgram all adverse events made knwn t them fr any vaccine. A list f vaccine abbreviatins is attached and is als lcated at: http://www.cdc.gv/vaccines/recs/acip/vac abbrev.htm
Vaccine Abbreviatin* Diphtheria and tetanus txids adsrbed (children) Diphtheria and tetanus txids and acellular pertussis vaccine adsrbed Diphtheria and tetanus txids and whle cell pertussis vaccine Diphtheria and tetanus txids and whle cell pertussis vaccine and Haemphilus influenzae type b cnjugate vaccine Tetanus and diphtheria txids adsrbed (adult) Tetanus txid, reduced diphtheria txid and acellular pertussis vaccine, adsrbed Tetanus txid Diphtheria and tetanus txids and acellular pertussis adsrbed and Haemphilus influenzae type b cnjugate vaccine Diphtheria and tetanus txids and acellular pertussis adsrbed, hepatitis B and inactivated plivirus vaccine Diphtheria and tetanus txids and acellular pertussis adsrbed and inactivated plivirus vaccine Diphtheria and tetanus txids and acellular pertussis adsrbed, inactivated plivirus and Haemphilus influenzae type b cnjugate vaccine Haemphilus influenzae type b cnjugate vaccine Haemphilus influenzae type b cnjugate and hepatitis B vaccine Hepatitis A vaccine DT DTaP DTP DTP-Hib Td Tdap TT DTaP/Hib DTaP-HepB- IPV DTaP-IPV DTaP-IPV/Hib Hib Hib-HepB HepA Hepatitis B vaccine HepB Hepatitis A inactivated and hepatitis B vaccine HepA-HepB Human papillmavirus vaccine (quadrivalent) HPV4 Human papillmavirus vaccine (bivalent) HPV2 Trivalent inactivated influenza vaccine TIV Live attenuated influenza vaccine LAIV Measles vaccine M Measles and rubella vaccine MR Measles, mumps, and rubella vaccine MMR Measles, mumps, rubella, and varicella vaccine MMRV
Meningcccal cnjugate vaccine (quadrivalent) MCV4 Meningcccal plysaccharide vaccine (quadrivalent) MPSV4 Pertussis P Pneumcccal cnjugate vaccine (7-valent) PCV7 Pneumcccal cnjugate vaccine (13-valent) PCV13 Plivirus vaccine (inactivated) IPV Plivirus vaccine (live) OPV Rubella vaccine R Rtavirus vaccine (mnvalent) RV1 Rtavirus vaccine (pentavalent) RV5 Varicella vaccine VAR *dash (-) indicates: prducts that are supplied in their final frm by the manufacturer and d nt require mixing r recnstitutin by user; slash ( / ) indicates: prducts that are mixed r recnstituted by user.